Literature DB >> 7014830

High-performance liquid chromatographic determination of ethmozin in plasma.

C C Whitney, S H Weinstein, J C Gaylord.   

Abstract

A sensitive, specific high-performance liquid chromatographic procedure was developed for the determination of plasma ethmozin levels. Basic plasma samples were partitioned with methylene chloride. The organic extract was washed with water and then evaporated to dryness under reduced pressure. The residue was redissolved in 0.2 ml of the mobile phase, consisting of hexane-tetrahydrofuran-methanol-water (66:27:6,30:0.7 v/v), and then chromatographed on a microporous silica column. With a variable-wavelength UV detector set at 268 nm, 10 ng of ethmozin/ml of plasma was measured. The utility of the method for human pharmacokinetic studies was demonstrated.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7014830     DOI: 10.1002/jps.2600700433

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  3 in total

Review 1.  Moricizine. A review of its pharmacological properties, and therapeutic efficacy in cardiac arrhythmias.

Authors:  A Fitton; M T Buckley
Journal:  Drugs       Date:  1990-07       Impact factor: 9.546

2.  Disposition of moracizine (ethmozine) in healthy subjects after oral administration of radiolabelled drug.

Authors:  D L Howrie; H J Pieniaszek; R N Fogoros; R P Juhl; W L Schary; C C Whitney; L W Dittert
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

Review 3.  New antiarrhythmic drugs.

Authors:  P F Nestico; J Morganroth; L N Horowitz
Journal:  Drugs       Date:  1988-03       Impact factor: 9.546

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.